<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910912-0128</DOCNO><DOCID>910912-0128.</DOCID><HL>   Amex Adds 24 Equity Options</HL><DATE>09/12/91</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><CO>   ADPT CS CBIO CYTO EPT FPP FH GENI GENZ IMNX ISP MTG PLRGEN RN RDC SEW BEAM OIL TSNG UBS VLSI XOMA</CO><IN>STOCK MARKET, OFFERINGS (STK)SECURITIES (SCR)</IN><RE>UNITED STATES (US)NORTH AMERICA (NME)NEW YORK (NY)</RE><LP>   NEW YORK -- The American Stock Exchange announced 24 newequity options it plans to list under new Securities andExchange Commission regulations, eligible for tradingbeginning Oct. 21.                                                                                                       </LP><TEXT>   The selections include Adaptec Inc., Cabletron SystemsInc., California Biotechnology Inc., Cytogen Corp., EpitopeInc., Fisher Price Inc., Foundation Health Corp., GeneticsInstitute Inc., Genzyme Corp., Immunex Corp., andInternational Specialty Products Inc.   Also included are MGIC Investment Corp., Pinelands Inc.,Repligen Corp., RJR Nabisco Holdings Corp. common, RJRNabisco Holdings Corp. preferred, Rowan Cos., Singer N.V.,Summit Technology Inc., Triton Energy Corp., Tseng Labs Inc.,U.S. Bioscience Inc., VLSI Technology Inc., and Xoma Corp.</TEXT></DOC>